Pharmafile Logo
Pharmafocus logo
Advanced Search
US Food and Drug Administration

FDA unveils changes to cancer drug review

September 14, 2011
Research and Development, Sales and Marketing Cancer, FDA, regulatory affairs

The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …

News
GlaxoSmithKline

GSK-Amicus start late-stage trials of Fabry disease treatment

September 14, 2011
Research and Development Amicus Therapeutics, Fabry disease, GSK

GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …

News

Novartis loses global development head to Gates Foundation

September 14, 2011
Research and Development Bill and Melinda Gates Foundation, Novartis, appointment

Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …

News

Government bites the bullet over A&E closure

September 14, 2011
NHS, NHS reform, hosptials

The government has backed the closure of the Accident and Emergency department at Chase Farm hospital in London, ending years …

News

The recast of the Restriction of Hazardous Substances (RoHS) Directive

September 13, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …

News
Press release
Novo Nordisk's Victoza (liraglutide)

Victoza data shows promise for early setting

September 13, 2011
Research and Development, Sales and Marketing Novo Nordisk, Victoza

New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …

News
Shanghai China flag

Betting big on research in China

September 13, 2011
Manufacturing and Production, Research and Development China, R&D

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …

Feature

AM-Pharma appoints new chief executive

September 13, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dutch biopharmaceutical company AM-Pharma has appointed Erik van den Berg as its new chief executive. He was previously VP business …

Appointment
Genzyme

Genzyme confirms further Fabrazyme delay

September 13, 2011
Manufacturing and Production Fabrazyme, Genzyme, pharma manufacturing news

Genzyme has been forced to delay shipments of its Fabry disease treatment Fabrazyme once again, blaming its “quality release process”. …

News

Slow Provenge growth prompts Dendreon staff cull

September 13, 2011
Business Services, Manufacturing and Production Dendreon, Provenge, job cuts, pharma manufacturing news

After months of building manufacturing capacity, US biotech Dendreon has decided to slash a quarter of its workforce – with …

News

Aurobindo forms Russian joint venture with Diod

September 13, 2011
Manufacturing and Production, Sales and Marketing Aurobindo, Diod, pharma manufacturing news

Indian drugmaker Aurobindo has formed a joint venture with Russia’s OJSC Diod in order to tap into the local market …

News

Offshoring pharma manufacturing increases risk, says study

September 12, 2011
Manufacturing and Production Puerto Rico, contract manufacturing, pharma manufacturing news

Drugs produced in offshore manufacturing plants – even those run by US manufacturers – pose a greater quality risk than …

News

Pharma manufacturing news in brief

September 12, 2011
Manufacturing and Production pharma manufacturing news

DMV-Fonterra agrees to buy India’s Brahmar Cellulose, plus there are facility updates from Reliable and Toyoba, some bad press for …

News
research_partnership_richard_head

Richard Head joins the Research Partnership

September 12, 2011
Sales and Marketing appointment, sales and marketing

Market research company the Research Partnership has appointed Richard Head as a director. He will be based at the company’s …

Appointment

FDA recommends Xarelto for new approval

September 12, 2011
Sales and Marketing Xarelto, atrial fibrillation, stroke

FDA advisors have recommended Bayer and Johnson & Johnson’s Xarelto be approved in the US for the prevention of stroke …

News

GSK scales back breast cancer trial

September 12, 2011
Research and Development, Sales and Marketing GSK, Tyverb

GSK has halted one of the four phase III studies that make up the ALTTO programme for its cancer drug …

News

Takeda moves potential first-in-class diabetes drug into phase III

September 12, 2011
Research and Development, Sales and Marketing TAK-875, Takeda, diabetes

Takeda has moved its potential first-in-class diabetes candidate TAK-875 into phase III clinical trials. The company hopes TAK-875 will offer …

News
Blog footer

Digital Pharma: Twitter slip-up shouldn’t silence pharma

September 9, 2011
Medical Communications, Sales and Marketing Bayer, Code of Practice, Digital Pharma blog, PMCPA, Twitter

Bayer UK was recently ruled to have breached the ABPI Code of Practice by promoting prescription-only medicines to the general …

News

Pan appoints trio of new starters

September 9, 2011
Medical Communications appointment, medical communications

Pan Advertising has appointed a trio of new starters across its creative and client services teams. Maneesh Sharma joins the …

Appointment
1hq_burton_paul

Branding agency 1HQ appoints Burton Paul

September 9, 2011
Medical Communications appointment, medical communications

Burton Paul has joined Windsor, UK-based branding agency 1HQ as client director to head up their health division. He has …

Appointment
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026